USPTO serial 79280719
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $325
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of osteoarthritis; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic medical preparations for the treatment of pain, fevers, headaches and inflammation; nutritional supplements for boosting energy; tonics being medicine for the treatment of fatigue and malnutrition; vitamin preparations; caffeine preparations for stimulative use; biological tissue for implantation for medical purposes; biological and chemical reagents for medical or veterinary purposes; diagnostic test reagents for medical or veterinary purposes; cultures of microorganisms for medical or veterinary use; fungicides; antibacterial preparations, other than for industrial purposes and laundry use, namely, antibacterial hand lotions, antibacterial spray, antibacterial cleaners, antibacterial substances for medical purposes, antibacterial alcohol skin sanitizer gel, antibacterial handwash, antibacterial soaps, antibacterial detergents, tissues impregnated with antibacterial preparations and antibacterial wipes; disinfectants; antiseptics; deodorizers, other than for industrial purposes, for the body, pets and breath freshening preparations; air deodorizers; room deodorizing compositions; odor neutralizing preparations for clothing and textiles; deodorants, other than for human beings or for animals, namely, deodorants for clothing and textiles, all purpose deodorizing preparations for household, commercial or industrial use, and all purpose disinfecting and deodorizing preparations; pesticides; insecticides; insect repellant preparations; vermin exterminating preparations; vermin repelling preparations; medicated toiletry preparations; dietetic food and substances adapted for medical or veterinary use; reagent paper for medical purposes; diapers for babies, adults and pets; diaper covers; incontinence diapers; bug catching adhesives; fly catching paper; fly catching adhesives; mothproofing paper; dietary supplements; dietary supplements for humans and animals, mainly composed of taurine; dietary supplements for humans and animals, mainly composed of herbs; dietary supplements for humans and animals, mainly composed of turmeric; dietary supplements for humans and animals, mainly composed of plant extracts; dietary supplements for humans and animals, mainly composed of vitamins; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; dietetic animal foodstuffs for medical purposes; semen for artificial insemination | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 17, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 17, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 1, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 1, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 14, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 24, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 24, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 10, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 20, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 7, 2021 | ALIE | ASSIGNED TO LIE | — |
| Sep 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 29, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 29, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 29, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 29, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 14, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 25, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 24, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 13, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |